Identification and validation of EPHX2 as a prognostic biomarker in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is one of the most common types of cancer, which is associated with a poor prognosis. It is necessary to identify novel prognostic biomarkers and therapeutic targets to improve the survival of patients with HCC. In the present study, a seven-gene signature associated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhan, Ke, Bai, Yang, Liao, Shengtao, Chen, Hongyu, Kuang, Lili, Luo, Qingqing, Lv, Lin, Qiu, Liewang, Mei, Zhechuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299194/
https://www.ncbi.nlm.nih.gov/pubmed/34278494
http://dx.doi.org/10.3892/mmr.2021.12289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299194/
https://www.ncbi.nlm.nih.gov/pubmed/34278494
http://dx.doi.org/10.3892/mmr.2021.12289

Ejemplares similares